
IndraLab
Statements
reach
"In contrast, one study showed that USP10 enhanced CRC cell proliferation by stabilizing MSI2, an oncogenic factor.Vismodegib, a drug used for treating basal cell carcinoma, has been shown to decrease the activity of two DUBs, USP25 and USP28, as well as the levels of their substrates, such as c-MYC, in CRC cells[30]."